Medicine & Life Sciences

1. Cell Transplantation 100%
2. Allogeneic Cells 53%
3. Transplants 40%
4. Graft vs Host Disease 34%
5. Bone Marrow 23%
6. Transplantation 22%
7. Survivors 19%
8. Survival 18%
9. Costs and Cost Analysis 16%
10. Multiple Myeloma 11%
11. Acute Myeloid Leukemia 10%
12. Quality of Life 10%
13. Hematopoietic Stem Cell Transplantation 10%
14. Leukemia 9%
15. Income 8%
16. Recurrence 8%
17. Tissue Donors 8%
18. Unrelated Donors 7%
19. Medicare 7%
20. Patient Reported Outcome Measures 7%
21. Survivorship 7%
22. Neoplasms 7%
23. Precursor Cell Lymphoblastic Leukemia-Lymphoma 7%
24. Mortality 7%
25. Busulfan 7%
26. Myelodysplastic Syndromes 6%
27. fludarabine 6%
28. Hematopoietic Stem Cells 6%
29. Clinical Trials 6%
30. Bone Marrow Transplantation 6%
31. Therapeutics 5%
32. Stem Cell Transplantation 5%
33. Siblings 5%
34. trans-crotonin 5%
35. Organized Financing 5%
36. Confidence Intervals 5%
37. Peripheral Blood Stem Cells 5%
38. Melphalan 5%
39. Hematologic Neoplasms 5%
40. Incidence 5%
41. Economics 5%